Scott Kelley, Chief Medical Officer at Flexion Therapeutics Inc (FLXN), sold 622 shares at $12.36 ($8K) on 2019-01-03, disclosed to the SEC on 2019-01-04.
Scheduled sale ($8k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |